Jennifer Young: Closing the Gap Between Cancer Innovation and Access in Europe
Jennifer Young/ LinkedIn and Elisabetta Zanon/ pharmaboardroom.com

Jennifer Young: Closing the Gap Between Cancer Innovation and Access in Europe

Jennifer Young, Vice President and Head, International Commercial Policy and Communications at Pfizer, shared on LinkedIn:

“Europe is a leader in cancer research. The challenge is getting that science to patients.

I recently joined a POLITICO Studio Podcast, sponsored by Pfizer, together with Elisabetta Zanon, CEO of the European Cancer Organisation, to discuss how Europe can close the gap between innovation and access.

The stakes are clear:

  • Five people in Europe are diagnosed with cancer every minute
  • Cancer costs the European economy more than €100 billion a year
  • Europe’s share of global commercial clinical trials has nearly halved in a decade
  • Five years on, Europe’s Beating Cancer Plan has strong ambitions, but delivery is falling short, and national cancer plans often lack the resources to succeed

With the Biotech Act under negotiation and the next long-term EU budget under discussion, this is a pivotal moment. Where I see the biggest opportunities to act:

  • Speed up clinical trials. Make Europe a more competitive place to run trials, so patients get earlier access to new options.
  •  Resource national cancer plans. Ambition needs funding and implementation to match.
  •  Narrow access gaps between member states. Where a patient lives shouldn’t determine whether they benefit from innovation.
  •  Give patients a real voice in policymaking. Better decisions start with those living with cancer.

Thank you to the POLITICO Studio team and to Elisabetta for the excellent dialogue.”

You can also read: